# Bowman Consulting Group Ltd.: financial statements, quarterly

BWMN · Nasdaq · CIK 1847590 · [Industrials](/sectors/industrials.md)

Pages: [Overview](/companies/bwmn.md) · [Financials](/companies/bwmn/financials.md) · [Filings](/companies/bwmn/filings.md) · [Insiders](/companies/bwmn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bwmn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [94.4](/filings/0001628280-24-046407.md) | [93.0 d](/filings/0001628280-25-012365.md) | [94.9](/filings/0001628280-25-023232.md) | [105](/filings/0001628280-25-039001.md) | [114](/filings/0001628280-25-050314.md) | [113 d](/filings/0001628280-26-015252.md) | [113](/filings/0001628280-26-031344.md) | [122](/filings/0001628280-26-055250.md) | [126](/filings/0001628280-25-050314.md) | [129 d](/filings/0001628280-26-015252.md) | [126](/filings/0001628280-26-031344.md) | [146](/filings/0001628280-26-055250.md) |
| Cost of revenue | $m | [45.7](/filings/0001628280-24-046407.md) | [46.1 d](/filings/0001628280-25-012365.md) | [46.9](/filings/0001628280-25-023232.md) | [49.6](/filings/0001628280-25-039001.md) | [54.3](/filings/0001628280-25-050314.md) | [53.0 d](/filings/0001628280-26-015252.md) | [54.8](/filings/0001628280-26-031344.md) | [56.5](/filings/0001628280-26-055250.md) | [59.1](/filings/0001628280-25-050314.md) | [58.0 d](/filings/0001628280-26-015252.md) | [60.6](/filings/0001628280-26-031344.md) | [68.4](/filings/0001628280-26-055250.md) |
| Selling, general and administrative | $m | [41.7](/filings/0001628280-24-046407.md) | [44.7 d](/filings/0001628280-25-012365.md) | [44.7](/filings/0001628280-25-023232.md) | [49.2](/filings/0001628280-25-039001.md) | [51.9](/filings/0001628280-25-050314.md) | [51.7 d](/filings/0001628280-26-015252.md) | [50.5](/filings/0001628280-26-031344.md) | [49.8](/filings/0001628280-26-055250.md) | [55.2](/filings/0001628280-25-050314.md) | [59.6 d](/filings/0001628280-26-015252.md) | [57.8](/filings/0001628280-26-031344.md) | [62.3](/filings/0001628280-26-055250.md) |
| Operating income | $m | [2.6](/filings/0001628280-24-046407.md) | [(3.7) d](/filings/0001628280-25-012365.md) | [(2.6)](/filings/0001628280-25-023232.md) | [(1.2)](/filings/0001628280-25-039001.md) | [0.4](/filings/0001628280-25-050314.md) | [1.4 d](/filings/0001628280-26-015252.md) | [1.1](/filings/0001628280-26-031344.md) | [9.0](/filings/0001628280-26-055250.md) | [5.3](/filings/0001628280-25-050314.md) | [4.2 d](/filings/0001628280-26-015252.md) | [0.1](/filings/0001628280-26-031344.md) | [8.1](/filings/0001628280-26-055250.md) |
| Income tax | $m | [(0.1)](/filings/0001628280-24-046407.md) | [2.1 d](/filings/0001628280-25-012365.md) | [(3.5)](/filings/0001628280-25-023232.md) | [(1.2)](/filings/0001628280-25-039001.md) | [(1.9)](/filings/0001628280-25-050314.md) | [(5.4) d](/filings/0001628280-26-015252.md) | [0.8](/filings/0001628280-26-031344.md) | [1.4](/filings/0001628280-26-055250.md) | [(3.3)](/filings/0001628280-25-050314.md) | [(0.5) d](/filings/0001628280-26-015252.md) | [0.4](/filings/0001628280-26-031344.md) | [(0.2)](/filings/0001628280-26-055250.md) |
| Net income | $m | [1.2](/filings/0001628280-24-046407.md) | [(7.7) d](/filings/0001628280-25-012365.md) | [(1.6)](/filings/0001628280-25-023232.md) | [(2.1)](/filings/0001628280-25-039001.md) | [0.8](/filings/0001628280-25-050314.md) | [5.9 d](/filings/0001628280-26-015252.md) | [(1.7)](/filings/0001628280-26-031344.md) | [6.0](/filings/0001628280-26-055250.md) | [6.6](/filings/0001628280-25-050314.md) | [2.0 d](/filings/0001628280-26-015252.md) | [(3.7)](/filings/0001628280-26-031344.md) | [2.5](/filings/0001628280-26-055250.md) |
| Diluted EPS | $ per share | [0.08](/filings/0001628280-24-046407.md) | not reported | [(0.11)](/filings/0001628280-25-023232.md) | [(0.13)](/filings/0001628280-25-039001.md) | [0.04](/filings/0001628280-25-050314.md) | not reported | [(0.11)](/filings/0001628280-26-031344.md) | [0.34](/filings/0001628280-26-055250.md) | [0.37](/filings/0001628280-25-050314.md) | not reported | [(0.22)](/filings/0001628280-26-031344.md) | [0.14](/filings/0001628280-26-055250.md) |
| Basic EPS | $ per share | [0.08](/filings/0001628280-24-046407.md) | not reported | [(0.11)](/filings/0001628280-25-023232.md) | [(0.13)](/filings/0001628280-25-039001.md) | [0.04](/filings/0001628280-25-050314.md) | not reported | [(0.11)](/filings/0001628280-26-031344.md) | [0.35](/filings/0001628280-26-055250.md) | [0.38](/filings/0001628280-25-050314.md) | not reported | [(0.22)](/filings/0001628280-26-031344.md) | [0.15](/filings/0001628280-26-055250.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [14.4](/filings/0001628280-23-037343.md) | [20.7](/filings/0001628280-25-012365.md) | [11.7](/filings/0001628280-24-021187.md) | [23.1](/filings/0001628280-24-035699.md) | [11.7](/filings/0001628280-24-046407.md) | [6.7](/filings/0001628280-26-015252.md) | [10.7](/filings/0001628280-25-023232.md) | [15.5](/filings/0001628280-25-039001.md) | [16.2](/filings/0001628280-25-050314.md) | [11.1](/filings/0001628280-26-055250.md) | [12.0](/filings/0001628280-26-031344.md) | [10.5](/filings/0001628280-26-055250.md) |
| Current assets | $m | [145](/filings/0001628280-23-037343.md) | [155](/filings/0001628280-25-012365.md) | [163](/filings/0001628280-24-021187.md) | [175](/filings/0001628280-24-035699.md) | [173](/filings/0001628280-24-046407.md) | [177](/filings/0001628280-26-015252.md) | [189](/filings/0001628280-25-023232.md) | [197](/filings/0001628280-25-039001.md) | [217](/filings/0001628280-25-050314.md) | [213](/filings/0001628280-26-055250.md) | [222](/filings/0001628280-26-031344.md) | [236](/filings/0001628280-26-055250.md) |
| Total assets | $m | [354](/filings/0001628280-23-037343.md) | [403](/filings/0001628280-25-012365.md) | [421](/filings/0001628280-24-021187.md) | [463](/filings/0001628280-24-035699.md) | [497](/filings/0001628280-24-046407.md) | [506](/filings/0001628280-26-015252.md) | [529](/filings/0001628280-25-023232.md) | [538](/filings/0001628280-25-039001.md) | [510](/filings/0001628280-25-050314.md) | [580](/filings/0001628280-26-055250.md) | [590](/filings/0001628280-26-031344.md) | [620](/filings/0001628280-26-055250.md) |
| Current liabilities | $m | [98.7](/filings/0001628280-23-037343.md) | [127](/filings/0001628280-25-012365.md) | [135](/filings/0001628280-24-021187.md) | [139](/filings/0001628280-24-035699.md) | [121](/filings/0001628280-24-046407.md) | [135](/filings/0001628280-26-015252.md) | [151](/filings/0001628280-25-023232.md) | [156](/filings/0001628280-25-039001.md) | [167](/filings/0001628280-25-050314.md) | [215](/filings/0001628280-26-055250.md) | [238](/filings/0001628280-26-031344.md) | [261](/filings/0001628280-26-055250.md) |
| Total liabilities | $m | [200](/filings/0001628280-23-037343.md) | [240](/filings/0001628280-25-012365.md) | [253](/filings/0001628280-24-021187.md) | [228](/filings/0001628280-24-035699.md) | [254](/filings/0001628280-24-046407.md) | [260](/filings/0001628280-26-015252.md) | [285](/filings/0001628280-25-023232.md) | [289](/filings/0001628280-25-039001.md) | [248](/filings/0001628280-25-050314.md) | [319](/filings/0001628280-26-055250.md) | [339](/filings/0001628280-26-031344.md) | [364](/filings/0001628280-26-055250.md) |
| Long-term debt | $m | [24.3](/filings/0001628280-23-037343.md) | [28.8](/filings/0001628280-24-010652.md) | [26.8](/filings/0001628280-24-021187.md) | [38.8](/filings/0001628280-24-035699.md) | [36.4](/filings/0001628280-24-046407.md) | [38.1](/filings/0001628280-25-012365.md) | [36.4](/filings/0001628280-25-023232.md) | [32.0](/filings/0001628280-25-039001.md) | [29.8](/filings/0001628280-25-050314.md) | [57.6](/filings/0001628280-26-015252.md) | [50.6](/filings/0001628280-26-031344.md) | [45.1](/filings/0001628280-26-055250.md) |
| Shareholders' equity | $m | [154](/filings/0001628280-24-046407.md) | [163](/filings/0001628280-26-015252.md) | [167](/filings/0001628280-25-039001.md) | [236](/filings/0001628280-25-050314.md) | [243](/filings/0001628280-25-050314.md) | [246](/filings/0001628280-26-055250.md) | [244](/filings/0001628280-26-055250.md) | [250](/filings/0001628280-26-055250.md) | [262](/filings/0001628280-25-050314.md) | [261](/filings/0001628280-26-055250.md) | [251](/filings/0001628280-26-055250.md) | [256](/filings/0001628280-26-055250.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [10.2 d](/filings/0001628280-24-046407.md) | [(0.5) d](/filings/0001628280-25-012365.md) | [2.5](/filings/0001628280-25-023232.md) | [3.1 d](/filings/0001628280-25-039001.md) | [6.8 d](/filings/0001628280-25-050314.md) | [11.9 d](/filings/0001628280-26-015252.md) | [12.0](/filings/0001628280-26-031344.md) | [4.3 d](/filings/0001628280-26-055250.md) | [10.2 d](/filings/0001628280-25-050314.md) | [9.4 d](/filings/0001628280-26-015252.md) | [11.6](/filings/0001628280-26-031344.md) | [(7.9) d](/filings/0001628280-26-055250.md) |
| Capital expenditure | $m | [1.4 d](/filings/0001628280-24-046407.md) | [0.0 d](/filings/0001628280-25-012365.md) | [0.3](/filings/0001628280-25-023232.md) | [0.3 d](/filings/0001628280-25-039001.md) | [0.2 d](/filings/0001628280-25-050314.md) | [(0.2) d](/filings/0001628280-26-015252.md) | [1.0](/filings/0001628280-26-031344.md) | [0.1 d](/filings/0001628280-26-055250.md) | [0.1 d](/filings/0001628280-25-050314.md) | [1.2 d](/filings/0001628280-26-015252.md) | [1.9](/filings/0001628280-26-031344.md) | [7.5 d](/filings/0001628280-26-055250.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-24-046407.md) | [0.7 d](/filings/0001628280-25-012365.md) | [0.0](/filings/0001628280-25-023232.md) | [2.1 d](/filings/0001628280-25-039001.md) | [11.9 d](/filings/0001628280-25-050314.md) | [9.4 d](/filings/0001628280-26-015252.md) | [4.1](/filings/0001628280-26-031344.md) | [5.4 d](/filings/0001628280-26-055250.md) | [0.0 d](/filings/0001628280-25-050314.md) | [9.3 d](/filings/0001628280-26-015252.md) | [9.2](/filings/0001628280-26-031344.md) | [3.0 d](/filings/0001628280-26-055250.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [11.8](/filings/0001628280-23-037343.md) | [12.7](/filings/0001628280-24-021187.md) | [12.3](/filings/0001628280-24-035699.md) | [13.8](/filings/0001628280-24-046407.md) | [13.8](/filings/0001628280-25-023232.md) | [16.3](/filings/0001628280-25-039001.md) | [16.8](/filings/0001628280-25-050314.md) | [16.4](/filings/0001628280-26-031344.md) | [16.6](/filings/0001628280-26-055250.md) | [16.9](/filings/0001628280-25-050314.md) | [16.5](/filings/0001628280-26-031344.md) | [16.6](/filings/0001628280-26-055250.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,335,512 at 2026-08-05, from the cover of the [10-Q filed 2026-08-10](/filings/0001628280-26-055250.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.